Angold Resources Ltd
OTC:AAUGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Angold Resources Ltd
OTC:AAUGF
|
CA |
|
COSCO SHIPPING Development Co Ltd
OTC:CITAF
|
CN |
|
Trident Resources Corp
OTC:EROSD
|
CA |
|
X
|
XP Chemistries AB
STO:XPC
|
SE |
|
U
|
Unitronix Corp
OTC:UTRX
|
US |
|
X
|
XIIlab Co Ltd
KOSDAQ:189330
|
KR |
|
E
|
Ekobot AB (publ)
STO:EKOBOT
|
SE |
|
Guanglian Aviation Industry Co Ltd
SZSE:300900
|
CN |
|
P
|
Pacific CMA Inc
OTC:PACC
|
US |
|
Aspen Digital Inc
OTC:ASPD
|
US |
|
M
|
McRae Industries Inc
OTC:MCRAA
|
US |
|
Indus Holding AG
OTC:INDHF
|
DE |
|
Rocket Doctor AI Inc
OTC:AIRDF
|
CA |
|
D
|
DongBang Medical Co Ltd
KOSDAQ:240550
|
KR |
Balance Sheet
Balance Sheet Decomposition
Angold Resources Ltd
Angold Resources Ltd
Balance Sheet
Angold Resources Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Apr-2021 | Apr-2022 | Apr-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
4
|
4
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
5
|
4
|
0
|
|
| PP&E Net |
10
|
10
|
11
|
2
|
0
|
4
|
8
|
7
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
10
N/A
|
11
+4%
|
12
+11%
|
2
-82%
|
0
-93%
|
8
+5 907%
|
12
+42%
|
7
-42%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
2
|
2
|
1
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+244%
|
2
+40%
|
2
+48%
|
1
-71%
|
0
-73%
|
0
+5%
|
0
-12%
|
|
| Equity | |||||||||
| Common Stock |
25
|
25
|
27
|
27
|
27
|
21
|
27
|
27
|
|
| Retained Earnings |
16
|
16
|
17
|
28
|
28
|
13
|
15
|
20
|
|
| Total Equity |
10
N/A
|
9
-4%
|
10
+8%
|
0
N/A
|
1
-53%
|
8
N/A
|
12
+43%
|
7
-42%
|
|
| Total Liabilities & Equity |
10
N/A
|
11
+4%
|
12
+11%
|
2
-82%
|
0
-93%
|
8
+5 907%
|
12
+42%
|
7
-42%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
8
|
8
|
9
|
9
|
1
|
8
|
13
|
14
|
|